Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells()()

Non–small cell lung carcinoma (NSCLC) is the most common cause of cancer deaths, with platin-based combination chemotherapy the most efficacious therapies. Gains in overall survival are modest, highlighting the need for novel therapeutic approaches including the development of next-generation platin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neoplasia
Auteurs principaux: Bar, Jair, Hasim, Mohamed S., Baghai, Tabassom, Niknejad, Nima, Perkins, Theodore J., Stewart, David J., Sekhon, Harmanjatinder S., Villeneuve, Patrick J., Dimitroulakos, Jim
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press 2016
Sujets:
Original article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031866/
https://ncbi.nlm.nih.gov/pubmed/27659012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.07.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires